BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24667078)

  • 1. Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis.
    Martínez-Taboada VM; López-Hoyos M; Narvaez J; Muñoz-Cacho P
    Autoimmun Rev; 2014 Aug; 13(8):788-94. PubMed ID: 24667078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis.
    Narváez J; Bernad B; Gómez-Vaquero C; García-Gómez C; Roig-Vilaseca D; Juanola X; Rodriguez-Moreno J; Nolla JM; Valverde J
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S57-62. PubMed ID: 18799055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for severe cranial ischaemic events in patients with giant cell arteritis.
    Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):88-93. PubMed ID: 28466802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
    Tzoran I; Brenner B; Sakharov G; Trujillo-Santos J; Lorenzo A; Madridano O; López-Sáez JB; Monreal M;
    Eur J Intern Med; 2014 Nov; 25(9):821-5. PubMed ID: 25287697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    Shao QY; Wang ZJ; Ma XT; Lin XZ; Pan L; Zhou YJ
    BMC Cardiovasc Disord; 2021 Dec; 21(1):574. PubMed ID: 34852763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
    Nesher G; Berkun Y; Mates M; Baras M; Rubinow A; Sonnenblick M
    Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of new-generation oral anticoagulant agents in patients receiving antiplatelet therapy after an acute coronary syndrome: systematic review and meta-analysis of randomized controlled trials.
    Komócsi A; Vorobcsuk A; Kehl D; Aradi D
    Arch Intern Med; 2012 Nov; 172(20):1537-45. PubMed ID: 23007264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis.
    Gonzalez-Gay MA; Piñeiro A; Gomez-Gigirey A; Garcia-Porrua C; Pego-Reigosa R; Dierssen-Sotos T; Llorca J
    Medicine (Baltimore); 2004 Nov; 83(6):342-347. PubMed ID: 15525846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell arteritis as a cause of first-ever stroke.
    Wiszniewska M; Devuyst G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):226-30. PubMed ID: 17630482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.
    Patti G; Pelliccia F; Gaudio C; Greco C
    Am J Cardiol; 2015 Mar; 115(6):837-43. PubMed ID: 25620037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
    Verheugt FW
    J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
    Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Chai-Adisaksopha C; Tantraworasin A; Phosuya C; Kanjanarat P; Chongruksut W; Sood MM; Thavorn K
    Ann Med; 2022 Dec; 54(1):80-97. PubMed ID: 34955074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
    Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
    Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A meta-analysis on efficacy of anti-platelet agents and anticoagulants for preventing stroke in patients with nonvalvular atrial fibrillation].
    Tu RH; Zhong GQ; Zeng ZY; Wu WF; He Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):262-7. PubMed ID: 21609534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.
    Broder MS; Sarsour K; Chang E; Collinson N; Tuckwell K; Napalkov P; Klearman M
    Semin Arthritis Rheum; 2016 Oct; 46(2):246-252. PubMed ID: 27378247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.